NP Pharma SRL
NP Pharma reported total assets of 62,642 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jul 2026).
The score of NP Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NP Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 37,694 € |
| Equity | 40,694 € |
| Cash | 54,332 € |
| EBITDA | 50,948 € |
| Total assets | 62,642 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jul 2026
NP Pharma's financial analysis
- Solvency65.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NP Pharma
NP Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1019.981.328
- VAT number
- BE1019981328
- Peppol
- Registered · 0208:1019981328 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Feb 2025
- Registered office
- 7030 Mons
- Latest accounts
- 2025 · filed on 04 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
NP Pharma (SRL) has been based in Mons since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 37,694 € and equity of 40,694 €; its revenue is not published. Its solvency stands at 65.0%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to NP Pharma
Companies in the same business, of comparable size and area, outside its group.
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
Frequently asked questions about NP Pharma
What is the revenue of NP Pharma?
NP Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NP Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1019981328 for NP Pharma, if the company is VAT-registered. Its company number (CBE) is 1019.981.328.
Where is the registered office of NP Pharma?
According to the CBE register, the registered office of NP Pharma is in 7030 Mons.
What is the equity of NP Pharma?
At the close of the 2025 financial year, the equity of NP Pharma amounts to 40,694 €, a solvency of 65.0% of total assets.
Who manages NP Pharma?
The register lists 1 active mandates at NP Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NP Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →